Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis YiFeng LiangLiMing GanALing Wang RESEARCH ARTICLE 26 April 2024
Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy Yanan CuiYanping ChenXiubao Ren RESEARCH ARTICLE 25 April 2024
How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study Marilina SanteroCarolina RequeijoXavier Bonfill Cosp RESEARCH ARTICLE Open access 25 April 2024
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023) María Ángeles Vaz-SalgadoBelén Cigarral GarcíaJuan Manuel Sepúlveda Sánchez CLINICAL GUIDES IN ONCOLOGY Open access 25 April 2024
Recent updates in the therapeutic uses of Pembrolizumab: a brief narrative review Vítor SilvaCristiano Matos REVIEW ARTICLE 24 April 2024
Akkermania muciniphila: a rising star in tumor immunology Leihan WangDong Tang REVIEW ARTICLE 23 April 2024
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey Olga Martínez-SáezJavier CortésMiguel Martín BRIEF RESEARCH ARTICLE Open access 23 April 2024
Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment Zheng WuTeng PanZhi-yu Wang RESEARCH ARTICLE 20 April 2024
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study Manuel Valladares-AyerbesMaria José Safontthe PERSEIDA investigators Research Article Open access 20 April 2024
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer Ying FuQing LiuXue Meng RESEARCH ARTICLE 18 April 2024
State of open science in cancer research Cristina RiusYiming LiuRut Lucas-Dominguez RESEARCH ARTICLE Open access 18 April 2024
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment Ke WangManyi XuZhengbo Song RESEARCH ARTICLE 16 April 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations Yanhua WangJingwen WeiZhengbo Song RESEARCH ARTICLE 16 April 2024
An overview of current research on cancer stem cells: a bibliometric analysis Xueyang ZhangWenbo DuNing Hu RESEARCH ARTICLE 16 April 2024
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis Yanqing YangWei ChenPengfei Gao RESEARCH ARTICLE 16 April 2024
Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study Abdul Qahar Khan YasinzaiBisma TareenAsad Ullah Research Article 14 April 2024
Prevalence and risk factors of thyroid nodules in breast cancer women with different clinicopathological characteristics: a cross-sectional study Chen-yu MaXin-yu LiangLing-quan Kong RESEARCH ARTICLE 12 April 2024
Exploring research progress in studying serum exosomal miRNA-21 as a molecular diagnostic marker for breast cancer Hang LiXiao-jing Tie REVIEW ARTICLE 11 April 2024
Clinical features and treatment outcomes of PD-1 inhibitor therapy in elderly patients (≥ 65 years) with advanced esophageal squamous cell carcinoma: a real-world study Yi YuTao WuJunhe Li RESEARCH ARTICLE 11 April 2024
Explainable and visualizable machine learning models to predict biochemical recurrence of prostate cancer Wenhao LuLin ZhaoWenlei Hou RESEARCH ARTICLE 11 April 2024
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies Qiaoqiao LiuFei YaoYuan Liao Review Article 11 April 2024
ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer Antonio Juan-RibellesFrancisco Bautistathe Sociedad Española de Hematología y Oncología Pediátrica (SEHOP) RESEARCH ARTICLE Open access 10 April 2024
The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review Wenxin DaZiyu SongJie Ma REVIEW ARTICLE 10 April 2024
Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer Song MiYunxin YangJiandong Zhang RESEARCH ARTICLE 10 April 2024
Evolution of radiation-induced dermatitis treatment Deng GuangmeiHe WeishanChen Jibing REVIEW ARTICLE 09 April 2024
Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures Lidan ChangDandan LiuHuafeng Kang RESEARCH ARTICLE 09 April 2024
Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma Zhaohui LiaoZhengyuan Xie RESEARCH ARTICLE 08 April 2024
Efficacy and safety of a combination treatment of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis Ying WangYalan SunBangshun He RESEARCH ARTICLE 08 April 2024
Genomic ancestry and cancer among Latin Americans Alejandro Ruíz-PatiñoLeonardo RojasAndrés Felipe Cardona SPECIAL ARTICLE Open access 06 April 2024
Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis Ana Luzarraga AznarVicente BebiaSilvia Cabrera RESEARCH ARTICLE 05 April 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study Álvaro Rodríguez-LescureJavier GallegoJuan de la Haba-Rodriguez RESEARCH ARTICLE Open access 05 April 2024
In vivo safety evaluation method for nanomaterials for cancer therapy Mengqi ChenJingyi HeiYong Huang REVIEW ARTICLE 04 April 2024
Fertility preservation in hematological cancer patients Dan LiYi-jun ZhaoCui-lian Zhang REVIEW ARTICLE 04 April 2024
Machine learning-driven prediction of brain metastasis in lung adenocarcinoma using miRNA profile and target gene pathway analysis of an mRNA dataset Young Wha KohJae-Ho HanHyun Woo Lee RESEARCH ARTICLE 03 April 2024
Development and validation of a novel scoring system based on a nomogram for predicting inadequate bowel preparation Xiaxia ZhaoYanglin PanXiaojun Huang RESEARCH ARTICLE 02 April 2024
Identification and validation of an immune-derived multiple programmed cell death index for predicting clinical outcomes, molecular subtyping, and drug sensitivity in lung adenocarcinoma Chunhong LiJiahua HuYiming Mao RESEARCH ARTICLE 02 April 2024
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data Yang LiuFenglong BieShugeng Gao RESEARCH ARTICLE 02 April 2024
Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC) Irene González CaraballoRocío Martín LozanoAndrés J. Muñoz Martín BRIEF RESEARCH ARTICLE 01 April 2024
A review of dose escalation for FDA-approved products treating solid tumors and hematological malignancies in first-in-human trials Zehui JiangWenxuan SunRui Yang REVIEW ARTICLE 01 April 2024
The effect of metabolic syndrome on prognosis of diffuse large B-cell lymphoma Wenjing XiongLiru LiShu Zhao RESEARCH ARTICLE Open access 30 March 2024
Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval Olajumoke Adenike OlatejuZhen ZengSujit S. Sansgiry RESEARCH ARTICLE 30 March 2024
Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway Zi-Yi FuYing HuangXiao-Hong Liu RESEARCH ARTICLE 30 March 2024
Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration Vered FuchsAriel SobarzoLaila Catalina Roisman RESEARCH ARTICLE Open access 29 March 2024
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study Alejandro Falcón GonzálezJosefina Cruz JuradoManuel Ruiz-Borrego RESEARCH ARTICLE Open access 28 March 2024
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP Aylen Vanessa OspinaSergio Bolufer NadalMariano Provencio RESEARCH ARTICLE Open access 26 March 2024
Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers Tianqi AnQiu HuiRuihua Zhao RESEARCH ARTICLE 26 March 2024
Logistic regression and other statistical tools in diagnostic biomarker studies Dina Mohamed Ahmed Samir ElkahwagyCaroline Joseph Kiriacos CLINICAL GUIDES IN ONCOLOGY Open access 26 March 2024
The prognostic value of vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma: a systematic review and meta-analysis Miaomiao WangLiang CaoJunqiang Lei RESEARCH ARTICLE 25 March 2024
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort Helena PlaEudald FelipSabela Recalde RESEARCH ARTICLE Open access 22 March 2024
Screening and treatment of latent tuberculosis in patients with solid tumors and systemic cancer therapy Miguel BorregónDavid SánchezElia Martínez REVIEW ARTICLE 21 March 2024
